BioSpace News Archive

Advanced glycation end products (AGEs) are a group of compounds that are usually developed via non-enzymatic reactions which occur between the carbonyl groups of reducing sugars & the free lipids, amino groups of proteins, or nucleic acids.

Regency Dental Care, a top-rated Palatine, IL implant dentistry offers affordable and permanent implant bridges and 1-day dental implants. The practice offers in-house plans and affordable financing on major and minor cosmetic and restorative treatments.

With the resolution, a directed share issue of approximately SEK 962 million (approximately USD 116 million) will be completed according to plan.

Incyte announced that the Japanese Ministry of Health, Labour and Welfare has approved Pemazyre®, a selective fibroblast growth factor receptor inhibitor, for the treatment of patients with unresectable biliary tract cancer with a fibroblast growth factor receptor 2 fusion gene1, worsening after cancer chemotherapy.

The Chronic Obstructive Pulmonary Disease Foundation and DevPro Biopharma LLC, a clinical research and development company, announced that the two organizations have entered into a strategic alliance to develop more effective treatments for people with chronic lung conditions and get them to patients sooner.

Initiated Phase 1 clinical trial for IDE397, a potential best-in-class MAT2A inhibitor for patients having tumors with MTAP-deletion

Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, announced that CEO Snehal Patel will participate in multiple events at the Benzinga Biotech Small-Cap Conference.

Sutter’s California Pacific Medical Center Cancer Center in San Francisco is the newest member of Caris’ collaborative network of oncology institutions

First Anti-PD-1 in Combination With Chemotherapy Approved for the First-Line Treatment of Esophageal and GEJ Carcinoma, Regardless of Histology or PD-L1 Expression

Pressing need to reduce the burden of chronic diseases are encouraging governments to offer research and development incentives